Blog Archives

Caradigm Kills eHealth, Partners with Orion

Today, Caradigm and Orion Health announced their partnership wherein Caradigm will go to market with Orion Health’s HIE solution suite and likewise Orion Health will take  Caradigm’s analytics solution, Caradigm Intelligence Platform (CIP) to market to its existing and future

Will Surescripts Become De facto NwHIN?

Just as Healtheway looks to ween itself off the federal gravy train, Surescripts comes along and in a couple of quick strokes looks ready to drive a stake into the heart of Healtheway or at least any desire Healtheway may have to become the Nationwide Health Information Network (NwHIN).

Looking Back on 2011 – What A Strange Year It’s Been

It is almost becoming the norm to say that it has been another tumultuous year in the healthcare IT market. Market consolidation, pushback on timelines, growing chorus from IT departments that enough is enough against the backdrop of the political

Microsoft Bows Out of the Clinical Market

Today, GE and Microsoft announced a joint venture (JV) that will lead to the formation of a new company (NewCo) targeting the clinical healthcare market sector. The NewCo will be located near Microsoft HQ in Redmond, WA, start with roughly 700

Stepping in Where Google Health Left Off

A little over a week ago Google stated that it was putting a stake through the heart of their personal health platform (PHP) Google Health. We at Chilmark had been expecting this for some time, it was just a manner

GE and Intel Target Telemed, Put $250M on Table

GE and Intel today jointly announced a partnership to address the healthcare telemedicine market, which they peg at $3B today, and more than doubling to $7.7B by 2012.  Companies agreed to pool $250M for R&D over the next five years. 

No Longer Just Chips at Intel

Late last week, Intel announced that it had received FDA approval or its consumer/caregiver centric health device, the Intel Health Guide. The Health Guide is a single purpose platform to facilitate telehealth by collecting data from devices (heart rate, weight,

Snap Shots from HIMSS

Here at the big, dare I say massive, healthcare IT (HIT) conference for the next couple of days. It is late, I’m exhausted, and the prose may not be the best, but wanted to give a few impressions/snap shots from

With Merger, Is WebMD Now in Play?

This morning, along with announcing very good 4th qtr growth at WebMD, a concurrent announcement was made that Healtheon and WebMD have agreed to merge, putting the value of the combined entity at about $2.3B. Due to the structure of

Predictions 2008: Telehealth Jumps, RHIOs Fade, Legislation Stalls & PHRs Get the Press

A common practice in the analyst community is to take a look back at what has occurred and project forward as to what we might see in the coming year. I won’t spend anytime on what has occurred as you

Philips Continues Buying Spree

Philips Electronics announced on Friday that it will acquire Respironics for $66/share or about $5.13 billion, a 24% premium.   This is the third and largest healthcare-centric acquisition that Philips has made in December.  The first was Emergin, a small

Update on the GE-Boston Scientific Partnership

Recently wrote a brief post on the GE-Boston Scientific partnership, but left a few questions unanswered awaiting a reply from one of the companies. Received an email today that helps clarify the partnership. First-off, it is an exclusive partnership between

GE and Boston Scientific Push Telehealth Envelop

Mid last week, GE and Boston Scientific made an interesting announcement wherein Boston Scientific’s patient monitoring platform, LATITUDE will be able to automatically update a patient’s Centricity-based electronic medical record (EMR). Currently, cardiologists use LATITUDE to remotely monitor a patient’s

Who We Are

Chilmark Research is the only industry analyst firm focusing solely on health IT. We combine proven research methodologies with intelligence and insight to provide cogent analyses of the emerging technologies that have the greatest potential to improve healthcare. We do not shy away from making tough calls, and are respected in the industry for our direct and thoughtful commentary.